Axsome Therapeutics (AXSM) is up 19.4%, or $28.82 to $177.61.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXSM:
- Axsome Therapeutics: Late-Stage CNS Pipeline and Regulatory Tailwinds Support Buy Rating
- Axsome Therapeutics rises 17.5%
- Axsome Advances AXS-12 Toward NDA Filing for Narcolepsy
- Axsome Therapeutics announces FDA acceptance, priority review of AXS-05 sNDA
- Axsome Therapeutics says AXS-12 NDA submission on track for January